Skip to main content
SpringerLink
Log in

Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy

  • Pancreatic And Biliary Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The present study was undertaken to investigate postprandial responses of cholecystokinin (CCK) and pancreatic polypeptide (PP) and their interrelationship in patients with diabetes mellitus (DM) with and without autonomic neuropathy (AN). Twenty-two patients with DM (seven with AN and 15 without AN) and 14 age-matched healthy controls were studied. AN was diagnosed according to several tests of cardiovascular autonomic function. CCK and PP plasma levels were measured by specific radioimmunoassays before and at several time points after the oral administration of a test meal. Basal CCK plasma levels in DM patients were normal, whereas basal PP plasma levels were increased (139±18 vs 72±7 pg/ml;P<0.01). Integrated postprandial CCK response was increased in DM patients (208±27 vs 110±14 pmol/liter/2 hr;P<0.05), mainly due to the patients with AN. Postprandial PP response was increased in DM patients without AN (37,273±5241 vs 13,418±3299 pg/ml/2 hr;P<0.001) but not in those with AN (8887±3461 pg/ml/2 hr). Moreover, PP response was closely (P<0.002) correlated with the degree of AN. A direct and linear correlation between postprandial CCK and PP responses was found in healthy controls (r=0.78;P<0.005) but not in DM patients. We conclude that the CCK response to a meal is increased in diabetic patients with AN, whereas the PP response is increased only with an intact autonomic nervous system. It is suggested that the correlation between postprandial hormonal responses in healthy subjects is due to the potency of CCK as PP releasing agent and that this interaction does not work in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cantor P: Cholecystokinin in plasma. Digestion 42:181–201, 1989

    PubMed  Google Scholar 

  2. Becker HD, Werner M, Schafmayer A: Release of radioimmunologic cholecystokinin in human subjects. Am J Surg 147:124–128, 1984

    PubMed  Google Scholar 

  3. Hopman WPM, Jansen JBMJ, Lamers CBHW: Plasma cholecystokinin response to a liquid fat meal in vagotomized patients. Ann Surg 200:693–697, 1984

    PubMed  Google Scholar 

  4. Hopman WPM, Jansen JBMJ, Lamers CBHW: Effect of atropine on the plasma cholecystokinin response to intraduodenal fat in man. Digestion 29:19–25, 1984

    PubMed  Google Scholar 

  5. Maton PN, Selden AC, Chadwick VS: Atropine inhibits meal-stimulated release of cholecystokinin. Scand J Gastroenterol 19:831–834, 1984

    PubMed  Google Scholar 

  6. Schwartz TW, Rehfeld JF, Stadil F, Larsson LI, Moon N, Chance RE: Pancreatic polypeptide response to food in duodenal ulcer patients before and after truncal vagotomy. Lancet 1:1102–1105, 1976

    PubMed  Google Scholar 

  7. Taylor IL, Impicciatore M, Walsh JH: Effect of atropine and vagotomy on the pancreatic polypeptide response to a meal. Am J Physiol 235:E443-E447, 1978

    PubMed  Google Scholar 

  8. Schwartz TW: Pancreatic polypeptide: A hormone under vagal control. Gastroenterology 85:1411–1425, 1983

    PubMed  Google Scholar 

  9. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A: Cholecystokinin is a regulator of intestinal phase-stimulated PP release. Regul Pept 30:105–111, 1990

    PubMed  Google Scholar 

  10. Meier R, Hildebrand P, Thumshirn M, Albrecht C, Studer B, Gyr K, Beglinger C: Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans. Gastroenterology 99:1757–1762, 1990

    PubMed  Google Scholar 

  11. Lugari R, Gnudi A, Dall'Argine P, Vattini A, Rignanese G, Dall'Aglio B, Melchionda N, Colella P, Luciani A, Toscani S, Zandomeneghi R: Diabetic autonomic neuropathy and impaired human pancreatic polypeptide secretion in response to food. J Clin Endocrinol Metab 64:279–282, 1987

    PubMed  Google Scholar 

  12. Hossdorf T, Wagner M, Hoppe HW: Pancreatic polypeptide (PP) response to food in type I diabetics with and without diabetic autonomic neuropathy. Hepatogastroenterology 35:238–241, 1988

    PubMed  Google Scholar 

  13. Floyd JC: Pancreatic polypeptide. Clin Gastroenterol 9:657–678, 1980

    PubMed  Google Scholar 

  14. Nakano I, Funakoshi A, Shinozaki H, Miyazaki K, Ibayashi H, Tateishi K, Hamaoka T: High plasma cholecystokinin response following ingestion of test meal by patients with non-insulin dependent diabetes mellitus. Regul Pept 14:229–236, 1986

    PubMed  Google Scholar 

  15. Mitsukawa T, Takemura J, Ohgo S, Mizuta M, Ii T, Kuribayashi T, Matsukura S: Gallbladder function and plasma cholecystokinin levels in diabetes mellitus. Am J Gastroenterol 85:981–985, 1990

    PubMed  Google Scholar 

  16. Levin AB: A simple test of cardiac function based upon the heart rate changes induced by the Valsalva manoevre. Am J Cardiol 18:90–99, 1966

    PubMed  Google Scholar 

  17. Ewing DJ, Campbell JW, Murray A, Neilson JM, Clarke BJ: Immediate heart response to standing: a simple test for autonomic neuropathy in diabetes. Br Med J 1:145–147, 1978

    PubMed  Google Scholar 

  18. Sundkvist G, Almer LO, Lilja B: Respiratory influence on heart rate in diabetes mellitus. Br Med J 1:924–925, 1979

    PubMed  Google Scholar 

  19. Cicmir IJ, Grüneklee D, Morquet A, Berger H, Kley HK, Lehmacher W, Gries FA: Studies of heart rate oscillations in diabetics at rest. Horm Metab Res 9(suppl):73–76, 1980

    Google Scholar 

  20. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916–918, 1982

    Google Scholar 

  21. Riepl RL, Fiedler F, Ernstberger M, Lehnert P: Effect of Na-taurodeoxycholate and phenylalanine on ecbolic pancreatic secretion and on plasma cholecystokinin in man. Eur J Clin Invest 22:A22, 1992

    Google Scholar 

  22. Taylor IL: RIA of the pancreatic polypeptide family. J Clin Immunol 10:43–49, 1987

    Google Scholar 

  23. Lonovics J, Guzman S, Devitt P, Hejtmancik KE, Suddith RL, Rayford PL, Thompson IC: Release of pancreatic polypeptide in humans by infusion of cholecystokinin. Gastroenterology 79:817–822, 1980

    PubMed  Google Scholar 

  24. Beglinger C, Meyer F, Häcki W, Gyr K: The release of pancreatic polypeptide by exogenous CCK in man and dog. Digestion 22:225–228, 1981

    PubMed  Google Scholar 

  25. Krarup T, Schwartz TW, Hilsted J, Madsbad S, Verlaege O, Sestoft L: Impaired response of pancreatic polypeptide to hypoglycemia: an early sign of autonomic neuropathy in diabetics. Br Med J 15:1544–1546, 1979

    Google Scholar 

  26. Levitt NS, Vinik AI, Sive AA, Van Tonder S, Lund A: Impaired pancreatic polypeptide responses to insulin induced hypoglycemia in diabetic autonomic neuropathy. J Clin Endocrinol Metab 50:445–449, 1980

    PubMed  Google Scholar 

  27. Polinsky RJ, Taylor IL, Chen P, Weise V, Kopin IJ: Pancreatic polypeptide responses to hypoglycemia in chronic autonomic failure. J Clin Endocrinol Metab 54:48–52, 1982

    PubMed  Google Scholar 

  28. Marco J, Hedo JA, Villanueva ML: Control of pancreatic polypeptide secretion by glucose in man. J Clin Endocrinol Metab 46:140–145, 1978

    PubMed  Google Scholar 

  29. Sive AA, Vinik AI, Van Tonder S: Pancreatic polypeptide (PP) response to oral and intravenous glucose in man. Am J Gastroenterol 71:183–185, 1979

    PubMed  Google Scholar 

  30. Marco J, Hedo JA, Castillo-Olivares J, Villanueva ML: Human pancreatic polypeptide secretion in conditions of exogenous and endogenous hyperglycemia. Diabetologia 19:418–422, 1980

    PubMed  Google Scholar 

  31. Kostic N, Zamaklar M, Novakovic R, Popovic S: The serum levels of gastrin, somatostatin, VIP and PP in diabetics with autonomic neuropathy. Eur J Endocrinol 130(suppl 2):157, 1994

    Google Scholar 

  32. Oster-Jorgensen E, Hilsted L, Thye-Ronn P, Qvist N: Post-prandial gallbladder emptying in diabetics related to gastric emptying rate and pancreatic polypeptide. Eur J Endocrinol 130(suppl 2):157, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Departments of Internal Medicine, Universities of Ulm and Bonn, Germany

    B. Glasbrenner MD, E. Dominguez-Munoz MD, R. L. Riepl, A. Vetsi MD & P. Malfertheiner MD

  2. Medizinische Klinik Innenstadt, University of Munich, Germany

    B. Glasbrenner MD, E. Dominguez-Munoz MD, R. L. Riepl, A. Vetsi MD & P. Malfertheiner MD

Authors
  1. B. Glasbrenner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Dominguez-Munoz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. L. Riepl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Vetsi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Malfertheiner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glasbrenner, B., Dominguez-Munoz, E., Riepl, R.L. et al. Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy. Digest Dis Sci 40, 406–411 (1995). https://doi.org/10.1007/BF02065429

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02065429

Key words

Search

Navigation